Topic: Health

Scientists have found a new way to treat glioblastoma, a type of brain cancer that is very hard to cure. The treatment uses a modified form of vitamin B12 and shows promise in laboratory tests.

Researchers at the Cleveland Clinic Foundation Taussig Cancer Center have been working on a new approach to treating glioblastoma. This type of brain cancer is extremely difficult to treat, and patients typically survive less than 15 months after diagnosis. One major reason for this is the blood-brain barrier, which blocks many drugs from reaching tumor tissue in the brain.

The researchers investigated nitrosylcobalamin (NO-Cbl), a modified form of vitamin B12 that releases nitric oxide. They tested NO-Cbl against cancer cells and found that it had antitumor activity across a wide range of cancer types. Tumor cells originating in the central nervous system displayed a moderate level of sensitivity to the treatment.

The study's most significant finding came from animal experiments. After being administered systemically, NO-Cbl successfully crossed the blood-brain barrier and accumulated preferentially within glioblastoma tissue. The researchers also found evidence that the compound remained active in tumors for an extended period.

In laboratory studies using human glioblastoma cells, combining NO-Cbl with either TRAIL or temozolomide produced much stronger suppression of tumor cell growth than any of the treatments achieved on their own. This suggests that NO-Cbl may be able to help overcome treatment resistance in some cases.

Why It Matters

This new approach has the potential to improve treatment options for patients with glioblastoma, a type of brain cancer that is very common in India. With more research, this could lead to better outcomes and longer survival times for those affected by this disease.

Key Facts

• Glioblastoma is an aggressive form of brain cancer that remains extremely difficult to treat.
• NO-Cbl, a modified form of vitamin B12, has antitumor activity across a wide range of cancer types.
• In animal experiments, NO-Cbl successfully crossed the blood-brain barrier and accumulated preferentially within glioblastoma tissue.

Key Terms

Glioblastoma

A type of brain cancer that is very hard to cure.

Implications

This new approach has the potential to improve treatment options for patients with glioblastoma, a type of brain cancer that is very common in India. With more research, this could lead to better outcomes and longer survival times for those affected by this disease.